MRI-Demonstrable Regression of a Pituitary Mass in a Case of Primary Hypothyroidism after a Week of Acute Thyroid Hormone Therapy
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Although magnetic resonance imaging (MRI) characteristics of pituitary gland hyperplasia in primary hypothyroidism have been previously described, the time span necessary for the regression of the hyperplasia in response to acute thyroid hormone (TH) therapy has not been defined. A 26-yr-old woman underwent 131I ablation 11 yr before admission. Intermittent poor compliance to levothyroxine (LT4) therapy led to inappropriately high serum thyroid-stimulating hormone (TSH) for her triiodothyronine (T3) and thyroxine (T4) levels. The patient was investigated to rule out TSH-secreting pituitary adenoma or resistance to TH. On admission, the patient's clinical features and thyroid function tests, as well as thyrotropin-releasing hormone (TRH) and acute T3 suppression tests, were in favor of profound primary hypothyroidism. MRI revealed symmetrical enlargement of the pituitary gland with distinct morphological characteristics of a macroadenoma. The patient began high-dose TH therapy and was rescanned six days later. The follow-up scan revealed a dramatic shrinkage of the pituitary gland. Four weeks later, serum T4 and TSH were within the normal range, and repeat MRI scan of the pituitary at that time showed a normal gland. This case is the first to document dramatic shrinkage of pituitary hyperplasia in long-standing primary hypothyroidism within one week of acute TH therapy. MRI alone is unable to reliably differentiate between a TSH-secreting pituitary adenoma and hypothyroidism-induced pituitary hyperplasia. Dynamic endocrine testing as well as repeat pituitary MRI after a brief TH trial may provide a firm diagnosis in similar cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thyroid hormone and the cardiovascular system
Klein, I. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90531-h · Cited by 370 · cited 1×
“Acute administration of a high dose of T3 should be considered as safe in young, otherwise healthy adults; however, in the setting of advanced age and/or the presence of atherosclerotic cardiovascular disease, this acute test should be avoided, as the precipitation or exacerbation of angina, arrthythmias, and congesti…”
BackgroundYAMADA, T., TSUKUI, T., IKEJIRI, K., YUKIMURA, Y., & KOTANI, M. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-5-817 · Cited by 104
Primary Hypothyroidism and Pituitary Enlargement: Radiological Evidence of Pituitary Regression
Jawadi, M. H. (1978) · Archives of Internal Medicine · doi:10.1001/archinte.1978.03630350079021 · Cited by 2
Cited by
Vidal, S., Horvath, E., Kovacs, K., Cohen, S. M., Lloyd, R. V., & Scheithauer, B. W. (2000) · Virchows Archiv · doi:10.1007/pl00008197 · Cited by 105
“Collectively, these findings may correlate with the pituitary’s vigorous response to thyroid hormone replacement in patients with primary hypothyroidism [ 52 ].”
Pituitary tumorous hyperplasia due to primary hypothyroidism
Han, L., Wang, J., Shu, K., & Lei, T. (2012) · Acta Neurochirurgica · doi:10.1007/s00701-012-1342-0 · Cited by 25
Ghannam, N. N., Hammami, M. M., Muttair, Z., & Bakheet, S. M. (1999) · Journal of Endocrinological Investigation · doi:10.1007/bf03343584 · Cited by 25
Pituitary adenoma secondary to primary hypothyroidism: Two case reports
Du, J., Ji, H., Jin, J., Gao, S., Yan, X., & Hu, S. (2020) · Medicine · doi:10.1097/md.0000000000019222 · Cited by 11
Roux, A., Rosso, D., Cuboni, D., Maccario, M., Grottoli, S., Arvat, E., & Gasco, V. (2024) · Biomedicines · doi:10.3390/biomedicines12061368 · Cited by 9
Dome-Shaped Pituitary Enlargement in Primary Hypothyroidism: Avoiding Neurosurgical Interventions
Fortis Hospital, K., Chakraborty, S., Tiwari, M., Palui, R., Bhattacharya, K., & Gangopadhyay, K. K. (2020) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.035.02.14 · Cited by 4
Cretinism presenting as a pseudotumour
Mahesh, D. M., Jebasingh, F. K., Baruah, M. P., & Thomas, N. (2015) · BMJ Case Reports · doi:10.1136/bcr-2014-206124 · Cited by 2
Metadata
- Authors
- Sarlis, N. J.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1997-03-01
- Volume
- 82
- Issue
- 3
- Pages
- 808-811
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2057681305
- Cited by
- 83
- References
- 3
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.